Journal of the American College of Cardiology
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial.
Patrick W Serruys, Akihiro Tobe, Niels van Royen, Ignacio J Amat-Santos, Martin Hudec, Matjaz Bunc, Ben J L Van den Branden, Peep Laanmets, Daniel Unic, Bela Merkely, Renicus S Hermanides, Vlasis Ninios, Marcin Protasiewicz, Benno J W M Rensing, Pedro L Martin
Published: 202510.1016/j.jacc.2025.10.076
Abstract
BACKGROUND: In the LANDMARK trial, the Myval balloon-expandable transcatheter heart valve (THV) series was noninferior to the most commonly used contemporary SAPIEN and Evolut Series THVs for the 30-day early safety endpoint in participants with symp…
Preview only. Read the full abstract at the source